Notably, about 70–80% of MSI colorectal tumors can be attributed to hypermethylation of the MLH1 promoter in CIMP cases [12, 13], although CIMP also occurs without MSI [14]. This evidence concerns the gene MLH1 and colorectal neoplasm.